Covaxin gets emergency use nod for children aged 2-18 years
Expert panel of the Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain conditions.With this, Covaxin becomes the first!-->!-->!-->…
Read More...
Read More...